Ribosomal protein L19 overexpression activates the unfolded protein response and sensitizes MCF7 breast cancer cells to endoplasmic reticulum stress-induced cell death

被引:38
作者
Hong, Mina [1 ]
Kim, HyungRyong [2 ]
Kim, Inki [1 ,3 ]
机构
[1] ASAN Med Ctr, ASAN Inst Life Sci, Seoul 138736, South Korea
[2] Wonkwang Univ, Dept Dent Pharmacol, Sch Dent, Iksan 570749, Chonbuk, South Korea
[3] Univ Ulsan, Dept Med, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Ribosomal protein L19; ER stress; Unfolded protein response; Breast cancer;
D O I
10.1016/j.bbrc.2014.06.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although first identified for their roles in protein synthesis, certain ribosomal proteins exert pleiotropic physiological functions in the cell. Ribosomal protein L19 is overexpressed in breast cancer cells by amplification and copy number variation. In this study, we examined the novel pro-apoptotic role of ribosomal protein L19 in the breast cancer cell line MCF7. Overexpression of RPL19 sensitized MCF7 cells to endoplasmic reticulum stress-induced cell death. RPL19 overexpression itself was not cytotoxic; however, cell death induction was enhanced when RPL19 overexpressing cells were incubated with endoplasmic reticulum stress-inducing agents, and this sensitizing effect was specific to MCF7 cells. Examination of the cell signaling pathways that mediate the unfolded protein response (UPR) revealed that overexpression of RPL19 induced pre-activation of the UPR, including phosphorylation of pERK-like ER kinase (PERK), phosphorylation of eukaryotic translation initiation factor 2 alpha (elF2 alpha), and activation of p38 MAPK-associated stress signaling. Our findings suggest that upregulation of RPL19 induces ER stress, resulting in increased sensitivity to ER stress and enhanced cell death in MCF7 breast cancer cells. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:673 / 678
页数:6
相关论文
共 15 条
[1]   Ribosomal protein L19 is a prognostic marker for human prostate cancer [J].
Bee, A ;
Ke, YQ ;
Forootan, S ;
Lin, K ;
Beesley, C ;
Forrest, SE ;
Foster, CS .
CLINICAL CANCER RESEARCH, 2006, 12 (07) :2061-2065
[2]   siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate Cancer [J].
Bee, Alix ;
Brewer, Daniel ;
Beesley, Carol ;
Dodson, Andrew ;
Forootan, Shiva ;
Dickinson, Timothy ;
Gerard, Patricia ;
Lane, Brian ;
Yao, Sheng ;
Cooper, Colin S. ;
Djamgoz, Mustafa B. A. ;
Gosden, Christine M. ;
Ke, Youqiang ;
Foster, Christopher S. .
PLOS ONE, 2011, 6 (07)
[3]   Ribosomal protein S7 as a novel modulator of p53-MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function [J].
Chen, D. ;
Zhang, Z. ;
Li, M. ;
Wang, W. ;
Li, Y. ;
Rayburn, E. R. ;
Hill, D. L. ;
Wang, H. ;
Zhang, R. .
ONCOGENE, 2007, 26 (35) :5029-5037
[4]   Bortezomib A Review of its Use in Patients with Multiple Myeloma [J].
Curran, Monique P. ;
McKeage, Kate .
DRUGS, 2009, 69 (07) :859-888
[5]   Inhibition of c-Myc activity by ribosomal protein L11 [J].
Dai, Mu-Shui ;
Arnold, Hugh ;
Sun, Xiao-Xin ;
Sears, Rosalie ;
Lu, Hua .
EMBO JOURNAL, 2007, 26 (14) :3332-3345
[6]  
Dressman MA, 2003, CANCER RES, V63, P2194
[7]   Making ribosomes [J].
Fatica, A ;
Tollervey, D .
CURRENT OPINION IN CELL BIOLOGY, 2002, 14 (03) :313-318
[8]   Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling [J].
Jeon, Y-J ;
Kim, I. K. ;
Hong, S-H ;
Nan, H. ;
Kim, H-J ;
Lee, H-J ;
Masuda, E. S. ;
Meyuhas, O. ;
Oh, B-H ;
Jung, Y-K .
ONCOGENE, 2008, 27 (31) :4344-4352
[9]   Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities [J].
Kim, Inki ;
Xu, Wenjie ;
Reed, John C. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :1013-1030
[10]   The ribosome in focus [J].
Maguire, BA ;
Zimmermann, RA .
CELL, 2001, 104 (06) :813-816